ADMA Biologics, Inc. (ADMA)
19.78
-0.60
(-2.92%)
USD |
NASDAQ |
Dec 12, 13:11
ADMA Biologics Gross Profit (Quarterly): 75.59M for Sept. 30, 2025
Gross Profit (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 256.99M |
| Vanda Pharmaceuticals, Inc. | 51.55M |
| Aldeyra Therapeutics, Inc. | -0.0637M |
| Arcutis Biotherapeutics, Inc. | 90.53M |
| Exelixis, Inc. | 579.18M |